v3.19.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 13,195 $ 9,811
Accounts receivable, net 82,585 76,919
Inventories 9,670 8,650
Prepaid assets 7,504 7,727
Other current assets 2,991 561
Total current assets 115,945 103,668
Property and equipment (net of accumulated depreciation and amortization of $54,512 and $50,127, respectively) 60,696 60,888
Operating lease right-of-use assets 19,734  
Intangible assets, net 137,844 140,029
Goodwill 196,298 197,892
Other assets 2,826 2,538
Total assets 533,343 505,015
Current liabilities    
Accounts payable 16,514 17,779
Accrued compensation 18,851 19,062
Accrued expenses and other current liabilities 18,327 8,986
Current portion of finance leases and obligations 6,501 6,298
Current portion of operating lease liabilities 3,620  
Current portion of loans 7,873 7,873
Pharma contract liability 1,017 927
Total current liabilities 72,703 60,925
Long-term liabilities    
Long-term portion of finance lease obligations 5,253 5,250
Long-term portion of operating lease liabilities 16,648  
Long-term portion of loans, net 85,995 87,880
Revolving credit facility 5,000 5,000
Other long term liabilities 3,740 3,060
Deferred income tax liability, net 20,156 22,457
Total long-term liabilities 136,792 123,647
Total liabilities 209,495 184,572
Commitments and contingencies - see Note L
Stockholders' equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 95,303,510 and 94,465,440 shares issued and outstanding, respectively) 95 94
Additional paid-in capital 378,571 372,186
Accumulated other comprehensive income (loss) (1,136) (579)
Accumulated deficit (53,682) (51,258)
Total stockholders’ equity 323,848 320,443
Total liabilities and stockholders' equity $ 533,343 $ 505,015

Source